Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Compulsive eating and weight gain related to dopamine agonist use

Identifieur interne : 003518 ( Main/Exploration ); précédent : 003517; suivant : 003519

Compulsive eating and weight gain related to dopamine agonist use

Auteurs : Melissa J. Nirenberg [États-Unis] ; Cheryl Waters [États-Unis]

Source :

RBID : ISTEX:47AAA15FC13290DBB65351837B9A150C1079A72B

Descripteurs français

English descriptors

Abstract

Dopamine agonists have been implicated in causing compulsive behaviors in patients with Parkinson's disease (PD). These have included gambling, hypersexuality, hobbyism, and other repetitive, purposeless behaviors (“punding”). In this report, we describe 7 patients in whom compulsive eating developed in the context of pramipexole use. All of the affected patients had significant, undesired weight gain; 4 had other comorbid compulsive behaviors. In the 5 patients who lowered the dose of pramipexole or discontinued dopamine agonist treatment, the behavior remitted and no further weight gain occurred. Physicians should be aware that compulsive eating resulting in significant weight gain may occur in PD as a side‐effect of dopamine agonist medications such as pramipexole. Given the known risks of the associated weight gain and obesity, further investigation is warranted. © 2005 Movement Disorder Society

Url:
DOI: 10.1002/mds.20757


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Compulsive eating and weight gain related to dopamine agonist use</title>
<author>
<name sortKey="Nirenberg, Melissa J" sort="Nirenberg, Melissa J" uniqKey="Nirenberg M" first="Melissa J." last="Nirenberg">Melissa J. Nirenberg</name>
</author>
<author>
<name sortKey="Waters, Cheryl" sort="Waters, Cheryl" uniqKey="Waters C" first="Cheryl" last="Waters">Cheryl Waters</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:47AAA15FC13290DBB65351837B9A150C1079A72B</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1002/mds.20757</idno>
<idno type="url">https://api.istex.fr/document/47AAA15FC13290DBB65351837B9A150C1079A72B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002A69</idno>
<idno type="wicri:Area/Istex/Curation">002A69</idno>
<idno type="wicri:Area/Istex/Checkpoint">001F78</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Nirenberg M:compulsive:eating:and</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16261618</idno>
<idno type="wicri:Area/PubMed/Corpus">002E08</idno>
<idno type="wicri:Area/PubMed/Curation">002E08</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002E05</idno>
<idno type="wicri:Area/Ncbi/Merge">001521</idno>
<idno type="wicri:Area/Ncbi/Curation">001521</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001521</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Nirenberg M:compulsive:eating:and</idno>
<idno type="wicri:Area/Main/Merge">004832</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:06-0244416</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001B73</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001148</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001B69</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Nirenberg M:compulsive:eating:and</idno>
<idno type="wicri:Area/Main/Merge">004C64</idno>
<idno type="wicri:Area/Main/Curation">003518</idno>
<idno type="wicri:Area/Main/Exploration">003518</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Compulsive eating and weight gain related to dopamine agonist use</title>
<author>
<name sortKey="Nirenberg, Melissa J" sort="Nirenberg, Melissa J" uniqKey="Nirenberg M" first="Melissa J." last="Nirenberg">Melissa J. Nirenberg</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Movement Disorders, Department of Neurology, Columbia University Medical Center, New York, New York</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Waters, Cheryl" sort="Waters, Cheryl" uniqKey="Waters C" first="Cheryl" last="Waters">Cheryl Waters</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Movement Disorders, Department of Neurology, Columbia University Medical Center, New York, New York</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2006-04">2006-04</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="524">524</biblScope>
<biblScope unit="page" to="529">529</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">47AAA15FC13290DBB65351837B9A150C1079A72B</idno>
<idno type="DOI">10.1002/mds.20757</idno>
<idno type="ArticleID">MDS20757</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Compulsive Behavior (chemically induced)</term>
<term>Compulsive Behavior (physiopathology)</term>
<term>Dopamine Agonists (adverse effects)</term>
<term>Dopamine agonist</term>
<term>Eating Disorders (chemically induced)</term>
<term>Eating Disorders (physiopathology)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Weight Gain (drug effects)</term>
<term>Weight gain</term>
<term>binge</term>
<term>compulsive eating</term>
<term>dopamine agonist</term>
<term>weight gain</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Dopamine Agonists</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Compulsive Behavior</term>
<term>Eating Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Weight Gain</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Compulsive Behavior</term>
<term>Eating Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Parkinson maladie</term>
<term>Prise poids</term>
<term>Stimulant dopaminergique</term>
<term>Système nerveux pathologie</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Dopamine agonists have been implicated in causing compulsive behaviors in patients with Parkinson's disease (PD). These have included gambling, hypersexuality, hobbyism, and other repetitive, purposeless behaviors (“punding”). In this report, we describe 7 patients in whom compulsive eating developed in the context of pramipexole use. All of the affected patients had significant, undesired weight gain; 4 had other comorbid compulsive behaviors. In the 5 patients who lowered the dose of pramipexole or discontinued dopamine agonist treatment, the behavior remitted and no further weight gain occurred. Physicians should be aware that compulsive eating resulting in significant weight gain may occur in PD as a side‐effect of dopamine agonist medications such as pramipexole. Given the known risks of the associated weight gain and obesity, further investigation is warranted. © 2005 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>État de New York</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="État de New York">
<name sortKey="Nirenberg, Melissa J" sort="Nirenberg, Melissa J" uniqKey="Nirenberg M" first="Melissa J." last="Nirenberg">Melissa J. Nirenberg</name>
</region>
<name sortKey="Waters, Cheryl" sort="Waters, Cheryl" uniqKey="Waters C" first="Cheryl" last="Waters">Cheryl Waters</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003518 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003518 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:47AAA15FC13290DBB65351837B9A150C1079A72B
   |texte=   Compulsive eating and weight gain related to dopamine agonist use
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024